This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

May 10–14, 2021
Shanghai and DigitalHybrid Event

Chen Gang, MD, MBA
VP of Clinical Development, CMO at Hepalink Ltd


Dr. Chen Gang graduated from Medical School of Jiaotong University as Medical physician; He was further trained as clinical pharmacologist in school of Medicine, University of Montreal, plus a MBA from Concordia University;  Chen Gang has accumulated over 20 years of industry experience, including 15+ years of hands on experiences in clinical development area; Chen Gang has been serving critical and leading role of medical/clinical development in Multinational companies including Boehringer Ingelgeim, Johnson&Johnson,AstraZeneca asia-pacific( Leading physician of infectious diseases), AstraZeneca China ( Head of medical science); He has also gained experience in China Based biopharma/ biotech companies including Hengrui Medicine as Sr. Medical Director of Oncology ( for developing its studies in overseas market), Chief Medical Officer of Sinomab Bioscience Ltd and supported Sinomab’s efforts in listing on HongKong stock exchange; Dr. Chen is presently VP of clinical development, CMO of Hepalink Group Ltd, and is responsible of establishing clinical development capability for the group.

Agenda Sessions

  • Fast forward: Innovation in China